亚宝药业四川制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
119
NMPA:119
Drug Approvals
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution
- Product Name
- 氨溴特罗口服溶液
- Approval Number
- 国药准字H20249378
- Approval Date
- Nov 15, 2024
NMPA
Desloratadine Oral Solution
- Product Name
- 地氯雷他定口服溶液
- Approval Number
- 国药准字H20244538
- Approval Date
- Jul 30, 2024
NMPA
Pediatric Paracetamol,Atificial Cow-bezoar and Chlorphenamine Maleate Granules
- Product Name
- 小儿氨酚黄那敏颗粒
- Approval Number
- 国药准字H14022942
- Approval Date
- Jun 14, 2024
NMPA
Erythromycin Estolate Granules
- Product Name
- 依托红霉素颗粒
- Approval Number
- 国药准字H14021306
- Approval Date
- Jun 14, 2024
NMPA
Montelukast Sodium Oral Granules
- Product Name
- 孟鲁司特钠颗粒
- Approval Number
- 国药准字H20243458
- Approval Date
- Apr 7, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
Clinical Trials
No trials found
News
No news found